Quantcast

Latest Bite Stories

2009-08-04 15:42:31

Any animal can bite, even cute, friendly ones that people have known for years, a U.S. veterinarian warns. If they are put in a new and threatening situation, they may bite, Dr. Kate Stenske of the University of Kansas in Manhattan said in a statement. To prevent bites from pets, it helps to recognize subtle signs of fear, nervousness or aggression in an animal, Stenske says. When it comes to strange dogs, Stenske says, it's best to never approach them, but if a strange dog approaches,...

2009-08-03 08:02:00

BETHESDA, Md., Aug. 3 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has received Orphan Drug Designation from the European Medicines Agency (EMEA) for BiTE antibody blinatumomab (MT103) for acute lymphoblastic leukemia (ALL). Blinatumomab is a novel therapeutic antibody that activates a patient's T cells to seek out and...

2009-07-30 09:07:28

 With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovarian cancer cells. Using the EphA2 protein as a molecular homing mechanism, chemotherapy was delivered in a highly selective manner in preclinical models of ovarian cancer, the researchers report in the July 29 issue of the Journal of the National Cancer Institute.EphA2 is attractive for such...

2009-07-30 08:15:00

BETHESDA, Md., July 30 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the pricing of its public offering of 14,000,000 shares of its common stock at a public offering price of $5.00 per share. All of the shares are being offered by Micromet. The gross proceeds to Micromet, before expenses, from the sale of the shares are expected...

2009-07-29 15:00:00

BETHESDA, Md., July 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole book running manager, with RBC Capital Markets as co-manager in this offering. The offering is being made pursuant to a shelf registration...

2009-07-27 06:00:00

BETHESDA, Md., July 27 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, August 6, 2009, at 9:00 am Eastern Time (3:00 pm Central European Time) to discuss its financial results for the second quarter of 2009. Micromet anticipates releasing its financial results at 7:00...

2009-07-22 10:38:00

NEW YORK, July 22 /PRNewswire-USNewswire/ -- When a dog or cat bites, an infection can follow. "Wounds that are most likely to become infected are those on the face and hands or when people wait more than eight hours before seeking medical attention," said Dr. Kate Stenske, a clinical assistant professor at Kansas State University's College of Veterinary Medicine. "If you are bitten, first wash the wound thoroughly with soap and water, and then call your physician right away." Stenske...

2009-07-22 11:50:34

Six rabid raccoons have been identified in New York City this year, the city health department said. Four of the raccoons were found in the Bronx, one in Manhattan near Inwood Hill Park, and one in Queens in Long Island City. Raccoons are the most commonly reported rabid animals in New York City, but city health officials warn that skunks, bats, stray dogs and cats and other wild animals can also carry rabies. Rabid raccoons are a relatively common occurrence in Staten Island and the Bronx,...

2009-07-21 14:50:42

A new DNA vaccine inhibited malignant melanoma, a deadly form of skin cancer, in mice by eliciting antibodies that target a gastrin-releasing peptide which is known to play a key role in cancer development. The researchers from China and the U.S. report their findings in the July 2009 issue of the journal Clinical and Vaccine Immunology.Gastrin-releasing peptide (GRP) is an important human peptide that regulates gastric acid secretion and motor function as well as elicits gastrin release....

2009-06-29 10:00:00

BETHESDA, Md., June 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it was added to the Russell 3000 Index as part of the annual reconstitution of the Russell indexes, which occurred on June 26, 2009. "Investors recognize the Russell 3000 as an established benchmark for tracking investment performance, market movements and...


Latest Bite Reference Libraries

0_e288c9a7e7e932afbeba3516c20e64f2
2009-06-16 22:38:30

The Brown Recluse Spider (Loxosceles reclusa) is a species of arachnid that is native to the USA from the southern Midwest south to the Gulf of Mexico. It can be found in Canada as well around southeast Ontario, and southern Quebec. Its range lies from southeastern Nebraska through southern Iowa, Illinois, and Indiana to southwestern Ohio. In the south, it is native from central Texas to western Georgia. It is not usually found west of the Rocky Mountains. Contrary to popular belief, this...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'